An antihypertensive substance associated with erythrocytes

Area of Science:

• Biochemistry
• Pharmacology
• Cardiovascular Research

Background:

• Hypertension remains a significant global health concern.
• Novel therapeutic targets and agents for hypertension are actively sought.
• Erythrocyte-derived factors may play a role in blood pressure regulation.

Purpose of the Study:

• To isolate and characterize a blood pressure-lowering factor from spontaneously hypertensive rat (SHR) erythrocytes.
• To investigate the mechanism of action, focusing on calcium uptake inhibition.
• To evaluate the efficacy of this factor in various experimental models of hypertension.

Main Methods:

• Preparation of an extract from hemolyzed SHR erythrocytes.
• Purification using Triton X-100 extraction, boiling, and Sephadex G-150 chromatography.
• In vitro assessment of calcium uptake in aortic segments.
• In vivo administration (intraperitoneal injection) to different hypertensive rat models (SHR, DOCA-NaCl, 1K,1C, 2K,1C).
• Measurement of systolic blood pressure (SBP) and assessment of effect duration.
• Enzymatic digestion with phospholipase D to probe the nature of the active compound.

Main Results:

• An antihypertensive factor (AHF) was isolated from erythrocytes.
• AHF demonstrated dose-dependent and reversible inhibition of lanthanum-resistant calcium uptake in aortic segments.
• Intraperitoneal administration of AHF significantly reduced SBP in SHR, DOCA-NaCl, 1K,1C, and 2K,1C rats.
• The duration of the antihypertensive effect varied across different models (2-8 days).
• AHF had minimal impact on the blood pressure of normotensive animals.
• Phospholipase D digestion abolished both blood pressure and calcium uptake effects.

Conclusions:

• An erythrocyte-derived antihypertensive factor (AHF) effectively lowers blood pressure across multiple hypertensive rat models.
• The mechanism involves the inhibition of calcium uptake, suggesting a role for phospholipids.
• AHF exhibits selectivity, primarily affecting hypertensive animals.
• Further investigation into the precise chemical structure and therapeutic potential of AHF is warranted.